Gelişiyor
Sağlık·1 g önceAI özeti
NHS Approves Teplizumab: A New Era in Type 1 Diabetes Treatment
The NHS in England and Wales is now offering teplizumab (Tzield), the first drug approved to delay the onset of type 1 diabetes. This treatment, administered as a 14-day infusion, works by slowing the immune system's attack on insulin-producing cells, potentially holding off full-blown diabetes for an average of three years.
T
Times of India